Dr. Bonomi Discusses Liquid Biopsies in Lung Cancer

Philip D. Bonomi, MD
Published: Tuesday, Oct 03, 2017



Philip D. Bonomi, MD, The Alice Pirie Wirtz Professor of Medical Oncology, Rush Medical College, medical oncologist, Rush University Medical Center, discusses liquid biopsies in lung cancer.

Liquid biopsies have emerged as an approach to better identify mutations in patients with cancer.

The advantages of liquid biopsies, says Bonomi, are that they are minimally invasive and allow physicians to follow their patient through treatment.
 
SELECTED
LANGUAGE


Philip D. Bonomi, MD, The Alice Pirie Wirtz Professor of Medical Oncology, Rush Medical College, medical oncologist, Rush University Medical Center, discusses liquid biopsies in lung cancer.

Liquid biopsies have emerged as an approach to better identify mutations in patients with cancer.

The advantages of liquid biopsies, says Bonomi, are that they are minimally invasive and allow physicians to follow their patient through treatment.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum OnlineJan 31, 20191.5
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x